Close Menu

NEW YORK – HTG Molecular Diagnostics reported after the close of the market on Tuesday that its second quarter revenues rose 18 percent year over year.  

For the three-month period ended June 30, the Tucson, Arizona-based firm's revenues rose to $5.8 million from $4.9 million in the year-ago quarter, beating the Wall Street estimate of $5.6 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.